| __timestamp | Amphastar Pharmaceuticals, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 24518692 |
| Thursday, January 1, 2015 | 46974000 | 19886580 |
| Friday, January 1, 2016 | 47298000 | 12631689 |
| Sunday, January 1, 2017 | 50918000 | 21977998 |
| Monday, January 1, 2018 | 58044000 | 20759000 |
| Tuesday, January 1, 2019 | 63109000 | 20838000 |
| Wednesday, January 1, 2020 | 65157000 | 121812000 |
| Friday, January 1, 2021 | 68920000 | 152137000 |
| Saturday, January 1, 2022 | 66592000 | 83231000 |
| Sunday, January 1, 2023 | 80393000 | 122706000 |
Data in motion
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Amphastar Pharmaceuticals, Inc. and TG Therapeutics, Inc. have taken different paths in this regard over the past decade. From 2014 to 2023, Amphastar's SG&A expenses grew steadily, peaking at approximately 80 million in 2023, marking a 99% increase from 2014. In contrast, TG Therapeutics saw a dramatic rise, with expenses surging by nearly 400% to around 123 million in the same period. This stark difference highlights TG Therapeutics' aggressive expansion strategy, while Amphastar's more controlled growth reflects a focus on operational efficiency. As investors and industry analysts look to the future, these trends offer valuable insights into each company's strategic priorities and financial health.
Comparing SG&A Expenses: Amgen Inc. vs TG Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Zoetis Inc. vs TG Therapeutics, Inc.
Selling, General, and Administrative Costs: argenx SE vs Amphastar Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Biogen Inc. and Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs TG Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Grifols, S.A. vs TG Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Cytokinetics, Incorporated or TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and Veracyte, Inc.
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Amphastar Pharmaceuticals, Inc. and Travere Therapeutics, Inc.